Nonalcoholic fatty liver disease (NAFLD) is the most common cause of liver disease
globally, and its prevalence is rapidly increasing. Nonalcoholic steatohepatitis (NASH), a …

The prevalence of obesity and the metabolic syndrome (MS) is on the rise, and
subsequently the hepatic manifestation of MS, nonalcoholic fatty liver disease (NAFLD), has …

Nonalcoholic fatty liver disease (NAFLD) and its more severe form, nonalcoholic
steatohepatitis (NASH), can promote the development of cirrhosis, hepatocellular …

Non-alcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in the West. Non-alcoholic steatohepatitis (NASH) is the progressive form of NAFLD and can …

Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease
worldwide. Despite its high prevalence and rising incidence, there are currently no specific …

Although the progress in the field of nonalcoholic steatohepatitis (NASH) pharmacological
treatment seems less spectacular compared with some other liver diseases, it has been …

Nonalcoholic fatty liver disease (NAFLD) is a global epidemic that is likely to become the
most common cause of chronic liver disease in the next decade, worldwide. Though …

Introduction: Non-alcoholic fatty liver disease (NAFLD) has become the most common
etiology for abnormal aminotransferase levels and chronic liver disease. Its growing …

Nonalcoholic fatty liver disease (NAFLD) is recognized as the most common cause of
chronic liver disease worldwide. NAFLD is a clinicopathologic syndrome ranging from …

Nonalcoholic fatty liver disease (NAFLD) is the most common liver disease in the developed
world, with prevalence estimates varying from 25% to 40% across different countries. 1, 2 In …